ADPKD

You have accessRestricted Access
Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD
Matthew B. Lanktree, Elsa Guiard, Pedram Akbari, Marina Pourafkari, Ioan-Andrei Iliuta, Syed Ahmed, Amirreza Haghighi, Ning He, Xuewen Song, Andrew D. Paterson, Korosh Khalili and York P.C. Pei

CJASN March 2021, 16 (3) 374-383; DOI: https://doi.org/10.2215/CJN.11100720

Add to Selected Citations
You have accessRestricted Access
Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression
Judith E. Heida, Ron T. Gansevoort, A. Lianne Messchendorp, Esther Meijer, Niek F. Casteleijn, Wendy E. Boertien, Debbie Zittema and on behalf of the DIPAK Consortium

CJASN February 2021, 16 (2) 204-212; DOI: https://doi.org/10.2215/CJN.10470620

Add to Selected Citations
You have accessRestricted Access
Long-Term Safety of Tolvaptan in ADPKD
Dipal M. Patel and Neera K. Dahl

CJASN January 2021, 16 (1) 3-5; DOI: https://doi.org/10.2215/CJN.17981120

Add to Selected Citations
Open Access
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Ronald D. Perrone, Jennifer Lee, Molly E. Hoke, Alvin Estilo and Olga Sergeyeva

CJASN January 2021, 16 (1) 48-58; DOI: https://doi.org/10.2215/CJN.10250620

Add to Selected Citations
Open Access
Preimplantation Genetic Testing for Monogenic Kidney Disease
Rozemarijn Snoek, Marijn F. Stokman, Klaske D. Lichtenbelt, Theodora C. van Tilborg, Cindy E. Simcox, Aimée D.C. Paulussen, Jos C.M.F. Dreesen, Franka van Reekum, A. Titia Lely, Nine V.A.M. Knoers, Christine E.M. de Die-Smulders and Albertien M. van Eerde

CJASN September 2020, 15 (9) 1279-1286; DOI: https://doi.org/10.2215/CJN.03550320

Add to Selected Citations
Open Access
A Patient Perspective on Genetic Testing for ADPKD
Dwight Odland

CJASN August 2020, CJN.14051119; DOI: https://doi.org/10.2215/CJN.14051119

Add to Selected Citations
You have accessRestricted Access
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan
Matteo Bargagli, Nasser A. Dhayat, Manuel Anderegg, Mariam Semmo, Uyen Huynh-Do, Bruno Vogt, Pietro Manuel Ferraro and Daniel G. Fuster

CJASN July 2020, 15 (7) 1007-1014; DOI: https://doi.org/10.2215/CJN.13861119

Add to Selected Citations
You have accessRestricted Access
A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials
Susan E. Shoaf, John Ouyang, Olga Sergeyeva, Alvin Estilo, Hui Li and Deborah Leung

CJASN May 2020, 15 (5) 643-650; DOI: https://doi.org/10.2215/CJN.08170719

Add to Selected Citations
You have accessRestricted Access
Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County
Tatsuya Suwabe, Shehbaz Shukoor, Alanna M. Chamberlain, Jill M. Killian, Bernard F. King, Marie Edwards, Sarah R. Senum, Charles D. Madsen, Fouad T. Chebib, Marie C. Hogan, Emilie Cornec-Le Gall, Peter C. Harris and Vicente E. Torres

CJASN January 2020, 15 (1) 69-79; DOI: https://doi.org/10.2215/CJN.05900519

Add to Selected Citations
Open Access
Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease
Irina M. Sanchis, Shehbaz Shukoor, Maria V. Irazabal, Charles D. Madsen, Fouad T. Chebib, Marie C. Hogan, Ziad El-Zoghby, Peter C. Harris, John Huston, Robert D. Brown and Vicente E. Torres

CJASN August 2019, 14 (8) 1151-1160; DOI: https://doi.org/10.2215/CJN.14691218

Add to Selected Citations

Main menu

User menu

Search

ADPKD

Pages

Articles

Information for Authors

About

Journal Information

More Information